Leavitt Chase C. Insider Trades

Insider Trading History

Track insider trading activity for Leavitt Chase C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $7.48k 14,200 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 14,200 shares
$9.18
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $44.6k 84,758 shares
Last Trade
Jan 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$117k 11,838 shares
$9.92
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $124k 235,000 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.66M 594,269 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $0 0 shares
Last Trade
Oct 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.21M 359,269 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $50.9k 96,596 shares
Last Trade
Jul 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$73.3k 10,305 shares
$7.11
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $56.3k 106,901 shares
Last Trade
Apr 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.9k 10,000 shares
$5.69
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $51k 96,901 shares
Last Trade
Apr 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.8k 15,000 shares
$5.52
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $111k 210,000 shares
Last Trade
Feb 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.03M 210,000 shares
$19.20
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $43.1k 81,901 shares
Last Trade
Jan 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$124k 6,091 shares
$20.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $46.3k 87,992 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$897k 43,125 shares
$20.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $23.6k 44,867 shares
Last Trade
Jan 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$172k 5,000 shares
$34.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $21k 39,867 shares
Last Trade
Jan 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$284k 8,500 shares
$33.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $29.2k 55,519 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 55,519 shares
$38.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $16.5k 31,367 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 29,867 shares
$48.60
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $790 1,500 shares
Last Trade
Jun 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$163k 1,500 shares
$108.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
General Counsel/secretary
Holding Value $0 0 shares
Last Trade
May 25, 2021 Sale
$30.8M 300,000 shares
$102.80
$0.53
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $839k 699,100 shares
Last Trade
Mar 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.7M 699,100 shares
$2.43
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $740k 616,700 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$426k 616,700 shares
$0.69
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $6k 5,000 shares
Last Trade
Aug 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.1k 5,000 shares
$1.02
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
General Counsel/secretary
Holding Value $150k 125,000 shares
Last Trade
Jul 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 125,000 shares
$1.10
$1.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up